Physician profile
Imaan Ansari
NPI 1972034304
$1,359.64
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2021: $246 · 2022: $557 · 2023: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $465.23 | 2019-2023 | Lo Loestrin Fe |
| Agile Therapeutics, INC. | $160.71 | 2022-2023 | Twirla |
| Exeltis, USA INC. | $109.37 | 2022-2023 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $99.11 | 2022-2023 | |
| Evofem Biosciences, INC. | $85.99 | 2021 | |
| Myovant Sciences INC. | $82.15 | 2022 | |
| Coopersurgical, INC. | $70.74 | 2023 | Wallach Cryosurgical Equipment, Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Exact Sciences Corporation | $54.76 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $45.47 | 2021-2022 | |
| Avion Pharmaceuticals | $44.22 | 2022-2023 | Balcoltra |
| Aspira Women'S Health INC | $37.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.25 | 2023 | |
| Sumitomo Pharma America, INC. | $27.53 | 2023 | Myfembree |
| Shield Therapeutics INC | $22.95 | 2023 | Accrufer |
| Pfizer INC. | $14.37 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imaan Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.